Investigation of Blood Clotting Influential Parameters for Hemostatic Powder Based on Blood Coagulation Mechanisms
DOI:
https://doi.org/10.63053/ijhes.211Keywords:
Blood coagulation, hemostatic powder, blood clotting, platelets, fibrinogen, coagulation factors, biological materials, hemostasis.Abstract
Hemorrhage is a major cause of preventable mortality in trauma, emergency medicine, and surgical procedures. Rapid and effective bleeding control is essential for improving patient survival. Hemostatic powders have emerged as promising biomaterials capable of accelerating blood coagulation through physical, chemical, and biological mechanisms. Their performance depends not only on physicochemical properties but also on physiological parameters regulating the coagulation process. Blood coagulation is a complex mechanism involving platelet activation, coagulation cascade reactions, fibrin formation, and clot stabilization. Various hematological and biochemical factors, including platelet count, fibrinogen concentration, thrombin activity, calcium ion levels, hematocrit, blood viscosity, pH, temperature, and coagulation factor function, significantly influence clot formation and stability. These parameters affect the interaction between blood components and hemostatic powders, thereby determining their hemostatic efficiency. This review discusses the key physiological parameters affecting blood coagulation and their impact on powder-based hemostatic agents. Recent developments in mineral, polysaccharide-based, clay, zeolite, chitosan-derived, and composite hemostatic powders are reviewed, with emphasis on their coagulation mechanisms, current challenges, and future perspectives for developing advanced hemostatic materials.
References
[1] World Health Organization, Injury and Violence Prevention Report, Geneva, Switzerland, 2023.
[2] B. Furie and B. C. Furie, "Mechanisms of thrombus formation," New England Journal of Medicine, vol. 359, no. 9, pp. 938–949, 2008.
[3] D. M. Kheirabadi, "Evaluation of topical hemostatic agents," Journal of Trauma and Acute Care Surgery, vol. 60, no. 6, pp. 1290–1297, 2006.
[4] M. Versteeg et al., "New fundamentals in hemostasis," Physiological Reviews, vol. 93, no. 1, pp. 327–358, 2013.
[5] S. Liang et al., "Recent advances in hemostatic biomaterials," Bioactive Materials, vol. 6, pp. 4169–4194, 2021.
[6] H. Li et al., "Advanced powder-based hemostatic materials for trauma management," Acta Biomaterialia, vol. 155, pp. 36–58, 2023.
[7] J. W. Mackman, "Coagulation in trauma and biomaterial interactions," Nature Reviews Materials, vol. 8, pp. 412–430, 2024.
[8] Hoffman, M., and Monroe, D. M., "A cell-based model of hemostasis," Thrombosis and Haemostasis, vol. 85, no. 6, pp. 958–965, 2001.
[9] Sadler, J. E., "Biochemistry and genetics of von Willebrand factor," Annual Review of Biochemistry, vol. 67, pp. 395–424, 1998.
[10] Jackson, S. P., "Arterial thrombosis—insidious, unpredictable and deadly," Nature Medicine, vol. 17, no. 11, pp. 1423–1436, 2011.
[11] Gailani, D., and Renné, T., "Intrinsic pathway of coagulation and Factor XII," Journal of Thrombosis and Haemostasis, vol. 5, pp. 1106–1112, 2007.
[12] Mackman, N., "The role of tissue factor in hemostasis and thrombosis," Nature Reviews Cardiology, vol. 9, pp. 638–647, 2012.
[13] Weisel, J. W., and Litvinov, R. I., "Fibrin formation and fibrin structure," Subcellular Biochemistry, vol. 82, pp. 405–456, 2017.
[14] Cesarman-Maus, G., and Hajjar, K. A., "Molecular mechanisms of fibrinolysis," British Journal of Haematology, vol. 129, no. 3, pp. 307–321, 2005.
[15] Monroe, D. M., Hoffman, M., and Roberts, H. R., "Platelets and thrombin generation," Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 22, pp. 1381–1389, 2002.
[16] Simin Jiao,Li, H., Wang, X., Zhang, Y., et al., "Recent advances in powder-based hemostatic biomaterials," Acta Biomaterialia, vol. 155, pp. 36–58, 2023.
[17] Monroe, D. M., and Hoffman, M., "What does it take to make the perfect clot?", Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 26, pp. 41–48, 2006.
[18] Ruggeri, Z. M., "Platelets in atherothrombosis," Nature Medicine, vol. 8, pp. 1227–1234, 2002.
[19] Liang, Y., et al., "Recent advances in hemostatic biomaterials for wound healing," Bioactive Materials, vol. 6, pp. 4169–4194, 2021.
[20] Levy, J. H., Goodnough, L. T., "How I use fibrinogen replacement therapy," Blood, vol. 125, no. 9, pp. 1387–1393, 2015.
[21] Yong Kiel Sung, et al., "Advances in the development of hemostatic biomaterials for medical application" Acta Biomaterialia, Vol 25, Issue 1. 12 Nov 2021.
[22] Martini, W. Z., "Coagulopathy by hypothermia and acidosis," Critical Care, vol. 13, no. 4, R119, 2009.
[23] Zhang, Y., Chen, L., et al., "Next-generation multifunctional hemostatic powders for trauma management," Advanced Functional Materials, vol. 34, 2024.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Authors
This work is licensed under a Creative Commons Attribution 4.0 International License.
Articles published in the International Journal of New Findings in Health and Educational Sciences (IJHES) are licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0).
You are free to:
-
Share — Copy and redistribute the material in any medium or format for any purpose, including commercially.
-
Adapt — Remix, transform, and build upon the material for any purpose, including commercially.
-
No Revocation — The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
-
Attribution — You must give appropriate credit to the original author(s) and the original publication, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in a way that suggests the author(s), IJHES, or the publisher endorses you or your use.
-
No Additional Restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Authors retain copyright in their work. By publishing with IJHES, authors grant the journal and Arvin Arena Scientific Publication the necessary non-exclusive rights to publish, reproduce, distribute, archive, and make the article publicly available.
Recommended attribution:
Author(s), “Article Title,” International Journal of New Findings in Health and Educational Sciences (IJHES), Year, DOI. Licensed under CC BY 4.0.
For the complete license terms, please refer to the Creative Commons Attribution 4.0 International License (CC BY 4.0).
